Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Roche’s Parkinson’s drug misses main goal in mid-stage trial

admin by admin
December 19, 2024
in Stock
0
Roche’s Parkinson’s drug misses main goal in mid-stage trial
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Investing.com — Roche’s experimental Parkinson’s disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial.

The Swiss pharmaceutical giant announced on Thursday that the drug did not significantly delay the progression of motor symptoms in early-stage Parkinson’s patients. This is the second setback this week for potential treatments for the neurodegenerative condition.

Earlier this week, UCB, a Belgian peer, declared that a similar Parkinson’s drug candidate developed in collaboration with Novartis (SIX:NOVN) also fell short of key objectives in a clinical trial.

Despite the setback, Roche stated that prasinezumab demonstrated potential clinical efficacy. The drug also showed positive trends on several other trial goals and was well tolerated by patients. Roche plans to continue evaluating the data and will collaborate with health authorities to determine the next steps.

Levi Garraway, Roche’s Chief Medical (TASE:PMCN) Officer, expressed belief in the drug’s potential, stating, “We believe the consistent efficacy trends from the Phase IIb study of prasinezumab merit further exploration.”

The latest study, which involved an expanded patient group of 586, echoed the results of a previous Roche mid-stage trial that also yielded mixed results earlier this year.

Parkinson’s disease, which currently has no cure, affects nearly 1 million people in the U.S. and more than 10 million globally. Several companies are developing treatments that target a neuronal protein called alpha-synuclein, which is found in the brain and associated with the disease.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

Previous Post

Cintas earnings beat by $0.08, revenue was in line with estimates

Next Post

Nordstrom stock rises as potential acquisition deal said near

admin

admin

Next Post
Nordstrom stock rises as potential acquisition deal said near

Nordstrom stock rises as potential acquisition deal said near

Trending News

Bank of America picks 5 stocks with post earnings rally potential

Bank of America picks 5 stocks with post earnings rally potential

August 2, 2025
Top gainers & losers today: Nifty, Sensex jump 2%, metals in the spotlight

Top gainers & losers today: Nifty, Sensex jump 2%, metals in the spotlight

April 12, 2025
US stocks unchanged on market open: S&P up 0.09%, Nasdaq up 0.19%

US stocks unchanged on market open: S&P up 0.09%, Nasdaq up 0.19%

June 3, 2025
Subscribe to Insightful Word


    Recent News

    Nvidia shares fall on China sales exclusion, weaker data center sales: analysts weigh in

    Nvidia shares fall on China sales exclusion, weaker data center sales: analysts weigh in

    August 28, 2025
    SentinelOne stock price forecast ahead of earnings: buy or sell?

    SentinelOne stock price forecast ahead of earnings: buy or sell?

    August 28, 2025
    Tesla wants millions of robotaxis by 2025, but will Waymo win the long game?

    Tesla wants millions of robotaxis by 2025, but will Waymo win the long game?

    August 28, 2025
    Urban Outfitters stock slides 4% despite strong quarter on cautious outlook

    Urban Outfitters stock slides 4% despite strong quarter on cautious outlook

    August 28, 2025

    Recent News

    Nvidia shares fall on China sales exclusion, weaker data center sales: analysts weigh in

    Nvidia shares fall on China sales exclusion, weaker data center sales: analysts weigh in

    August 28, 2025
    SentinelOne stock price forecast ahead of earnings: buy or sell?

    SentinelOne stock price forecast ahead of earnings: buy or sell?

    August 28, 2025

    Latest News

    • Nvidia shares fall on China sales exclusion, weaker data center sales: analysts weigh in
    • SentinelOne stock price forecast ahead of earnings: buy or sell?
    • Tesla wants millions of robotaxis by 2025, but will Waymo win the long game?

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.